Summary
The study objective was to determine the specificity and sensitivity of plasma concentrations of D-dimer, a fibrin degradation product, as a marker for ongoing thrombotic and thrombolytic events in pulmonary embolism. A prospective study was performed in 74 patients with suspected pulmonary embolism who appeared in the emergency room with dyspnea and/or chest pain.
The presence of pulmonary embolism was established by positive findings either in pulmonary angiography or lung scan. D-dimer concentrations were determined in all patients. In 11 patients with positive pulmonary angiography, D-dimer concentrations were monitored for 6–12 days.
D-dimer concentrations were determined by a quantitative enzyme-linked immunoassay. Plasma probes of 26 patients (16 with/10 without positive pulmonary angiography) were reassayed with a semiquantitative latex agglutination assay. D-dimer levels were significantly higher in patients with pulmonary embolism (>1000 ng/mL in 41 out of 43) than in those without (<1000 ng/mL in all 21 patients) (p<0.01).
The sensitivity and specificity for the ELISA were found to be 95% and 100%, respectively, for establishing the diagnosis of pulmonary embolism. In the latex assay the values were 81% and 60%, respectively.
It is concluded that in patients with dyspnea and/or chest pain, determination of D-dimer in plasma by ELISA adds a valuable tool to the noninvasive diagnostic procedure for pulmonary embolism. From the time-course of D-dimer values we conclude that this assay might be valuable up to at least 6 days after symptom onset. The assay, however, is unreliable in malignancies or after surgery.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- apPE:
-
angiographically proven pulmonary embolism
- hpPE:
-
highly probable pulmonary embolism
- imPE:
-
highly improbable pulmonary embolism
- rPE:
-
pulmonary embolism ruled out
- pPE:
-
possible pulmonary embolism
References
Alderson PO, Biello DR, Sachariah KG, Siegel BA (1981) Scintigraphic detection of pulmonary embolism in patients with obstructive pulmonary disease. Radiology 138:661–666
Barritt DW, Jordan SC (1960) Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet I:1309–1312
Bounameaux H, Cirafici P, De Moerloose P, Schneider PA, Slosman D, Reber G, Unger PF (1991) Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet 337:196–200
Branch WT, McNeil BJ (1983) Analysis of the differential diagnosis and assessment of pleuritic chest pain in young adults. Am J Med 75:671–679
Bridey F, Phlipotteau C, Dreyfus M, Simonneau G (1989) Plasma D-dimer and pulmonary embolism. Lancet 1:791–792
Cheely R, McCartney WH, Perry JR, Delany DJ, Bustad L, Wynia VH, Griggs TR (1981) The role of noninvasive tests versus pulmonary angiography in the diagnosis of pulmonary embolism. Am J Med 70:17–22
Coon WW (1976) The spectrum of pulmonary embolism. Arch Surg 111:398–402
Dalen JE, Alpert JS (1975) Natural history of pulmonary embolism. Prog Cardiovasc Dis 17:259–270
Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Mascí PP, Whithaker AN (1986) Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles. Am J Clin Pathol 85:360–364
Fischer KC, McNeil B (1979) The indeterminate lung scan: its characteristics and its association with pulmonary embolism. Eur J Nucl Med 4:49–53
Franke M, Hafter R, von Hugo R, Röbl M, Graeff H (1986) Ein Test zum Nachweis von Fibrin im Plasma. Geburtshilfe Frauenheilkd 46:105–109
Gaffney PJ, Creighton LJ, Callus M, Thorpe R (1988) Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II: Evaluation in a variety of clinical conditions. Br J Haematol 68:91–96
Goldhaber SZ, Vaughan DE, Tumeh SS, Loscalzo J (1988) Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism. Am Heart J 116:505–508
Hull RD, Hirsh J, Carter CJ, Jay RM, Dodd PE, Ockelford PA, Coates G, Gill GJ, Turpie AG, Doyle DJ, Buller HR, Raskob GE (1983) Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Int Med 98:891–899
Hunt FA, Rylatt DB, Hart R-A, Bundesen PG (1985) Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation of fibrinolytic systems. Br J Haematol 60:715–722
Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE (1987) Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery diseases. N Engl J Med 317:1361–1365
Müller-Berghaus G, Scheefers-Borchel U, Selmayr E, Henschen A (1986) Fibrinogen and its derivatives. Elsevier, Amsterdam New York
Murray HW, Ellis GC, Blumenthal DS, Sos TA (1979) Fever and pulmonary thromboembolism. Am J Med 67:232–235
Reilly BM (1984) Practical strategies in outpatient medicine. Saunders, Philadelphia
Stötzer K-E, Amiral J, Spanuth E (1988) Neue Methoden zur spezifischen Bestimmung von Fibrinspaltprodukten (D-Dimere). Lab Med 12:51–55
Szucs MM, Brooks HL, Grossman W, Banas JS, Meister SG, Dexter L, Dalen JE (1971) Diagnostic sensitivity of laboratory findings in acute pulmonary embolism. Ann Intern Med 74:161–166
The PIOPED Investigators (1990) Value of the ventilation/ perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 263:2753–2759
Van Hulsteijn H, Bertina R, Briet E (1982) A one-year follow-up study of plasma fibrinopeptide A and beta-thromboglobulin after deep vein thrombosis and pulmonary embolism. Thromb Res 27:225–229
Whitaker AN, Elms MJ, Masci PP, Bundesen PG, Rylatt DB, Webber AJ, Bunce IH (1984) Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies. J Clin Pathol 37:882–887
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lichey, J., Reschofski, I., Dissmann, T. et al. Fibrin degradation product D-dimer in the diagnosis of pulmonary embolism. Klin Wochenschr 69, 522–526 (1991). https://doi.org/10.1007/BF01649289
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01649289